MedPath

University Of California, San Francisco

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA)

Phase 2
Completed
Conditions
Prostate Cancer
Interventions
First Posted Date
2008-05-15
Last Posted Date
2017-08-23
Lead Sponsor
University of California, San Francisco
Target Recruit Count
30
Registration Number
NCT00678054
Locations
🇺🇸

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Pharmacokinetic and Efficacy Study of Nordihydroguaiaretic Acid (NDGA) in Non Metastatic Recurrent Prostate Cancer

Phase 2
Terminated
Conditions
Prostate Cancer
Interventions
Drug: Nordihydroguaiaretic Acid (NDGA)
First Posted Date
2008-05-15
Last Posted Date
2014-04-09
Lead Sponsor
University of California, San Francisco
Target Recruit Count
12
Registration Number
NCT00678015
Locations
🇺🇸

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Philippine Child Health and Policy Experiment

Not Applicable
Completed
Conditions
Childhood Illness
Interventions
Other: Bonus/Pay-for-Performance Intervention
Other: Access Intervention
First Posted Date
2008-05-15
Last Posted Date
2015-05-04
Lead Sponsor
University of California, San Francisco
Registration Number
NCT00678197

Effect of Endothelin-1 Receptor Blockade on Circulating Endothelial Microparticles Levels in Patients With Pulmonary Hypertension

Completed
Conditions
Pulmonary Hypertension
First Posted Date
2008-05-08
Last Posted Date
2016-10-27
Lead Sponsor
University of California, San Francisco
Target Recruit Count
20
Registration Number
NCT00675051
Locations
🇺🇸

University of California, San Francisco, California, United States

Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 Patients

Not Applicable
Completed
Conditions
HIV Infections
Interventions
First Posted Date
2008-05-06
Last Posted Date
2013-07-05
Lead Sponsor
University of California, San Francisco
Target Recruit Count
18
Registration Number
NCT00672932
Locations
🇺🇸

Ucsf Ccrc, Sfgh, San Francisco, California, United States

Prenatal Steroids for Treatment of Congenital Cystic Adenomatoid Malformations (CCAM)

Phase 1
Terminated
Conditions
Congenital Cystic Adenomatoid Malformation
Interventions
Drug: Placebo
First Posted Date
2008-05-02
Last Posted Date
2015-03-30
Lead Sponsor
University of California, San Francisco
Target Recruit Count
1
Registration Number
NCT00670956
Locations
🇺🇸

University of California, San Francisco Fetal Treatment Center, San Francisco, California, United States

🇺🇸

Cincinnati Children's Hospital, Cincinnati, Ohio, United States

🇺🇸

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Weight-Bearing Magnetic Resonance Imaging (MRI) for Analysis of Knee Osteoarthritis (OA)

Completed
Conditions
Osteoarthritis
Interventions
Radiation: X-ray; magnetic resonance imaging
First Posted Date
2008-04-24
Last Posted Date
2009-04-17
Lead Sponsor
University of California, San Francisco
Target Recruit Count
33
Registration Number
NCT00665548
Locations
🇺🇸

University of California - San Francisco, San Francisco, California, United States

Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection

First Posted Date
2008-04-21
Last Posted Date
2013-05-27
Lead Sponsor
University of California, San Francisco
Target Recruit Count
10
Registration Number
NCT00662545
Locations
🇺🇸

San Francisco General HIV Clinical Trials Group, San Francisco, California, United States

Impact of Extensive Consultation on Career Development Grant Outcomes

Not Applicable
Completed
Conditions
Career Development Grant Outcomes
Interventions
Other: Extensive Consultations
First Posted Date
2008-04-21
Last Posted Date
2018-10-11
Lead Sponsor
University of California, San Francisco
Target Recruit Count
132
Registration Number
NCT00662402
Locations
🇺🇸

University of California, San Francisco, San Francisco, California, United States

Effect of Timi3 Ultrasound on Myocardial Blow Flow in the Hibernating Myocardium

Early Phase 1
Terminated
Conditions
Myocardial Ischemia
First Posted Date
2008-04-09
Last Posted Date
2012-04-04
Lead Sponsor
University of California, San Francisco
Target Recruit Count
9
Registration Number
NCT00655070
Locations
🇺🇸

UC San Francisco, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath